Development and validation of an electrochemiluminescent ELISA for quantitation of oral insulin tregopil in diabetes mellitus serum

被引：4
作者：
Ramaswamy, Shilpa G. [1 ]
Nayak, Vivek G. [1 ]
Jha, Sumit Kumar [1 ]
Hegde, Vishika [1 ]
Waichale, Vinit S. [1 ]
Melarkode, Ramakrishnan [1 ]
Chirmule, Narendra [1 ]
Rao, Anita U. [1 ]
Sengupta, Nilanjan [1 ]
机构：
[1] Biocon Res Ltd, Res & Dev, Biocon Special Econ Zone, Plot 2 & 3,Phase 4 BIA,Bommasandra Jigani Link Rd, Bangalore 560099, Karnataka, India
来源：
BIOANALYSIS | 2017年 / 9卷 / 13期
关键词：
diabetes; ECL; ELISA; oral insulin; pharmacokinetics; tregopil; ANALOG; RADIOIMMUNOASSAY;
D O I：
10.4155/bio-2017-0020
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Aim: Tregopil, a novel PEGylated human insulin is in clinical development for oral delivery in diabetes treatment. The aim of the study was to develop and validate a sensitive and specific ELISA method for quantitating Tregopil in diabetes subjects on basal Glargine, since most commercially available insulin kits either do not detect Tregopil or show significant reactivity to Glargine. Methods: An electrochemiluminescent ELISA was developed and validated for Tregopil quantitation in diabetes serum. Results: The method has a LLOQ of 0.25 ng/ml, shows minimum cross-reactivity to Glargine and was successfully tested using a subset of samples from Tregopil-dosed Type 1 diabetes mellitus patients. Conclusion: The ELISA method is sensitive and can be used to support accurate measurement of Tregopil with no c-ross-reactivity to Glargine and its metabolites in clinical studies.
引用
收藏
页码：975 / 986
页数：12
相关论文
共 21 条
  • [1] A new insulin immunoassay specific for the rapid-acting insulin analog, insulin aspart, suitable for bioavailability, bioequivalence, and pharmacokinetic studies
    Andersen, L
    Jorgensen, PN
    Jensen, LB
    Walsh, D
    [J]. CLINICAL BIOCHEMISTRY, 2000, 33 (08) : 627 - 633
  • [2] Validity and use of a non-parallel insulin assay for pharmacokinetic studies of the rapid-acting insulin analogue, insulin aspart
    Andersen, L
    Volund, A
    Olsen, KJ
    Plum, A
    Walsh, D
    [J]. JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY, 2001, 22 (02) : 147 - 163
  • [3] [Anonymous], 2013, GUID IND BI IN PRESS
  • [4] [Anonymous], 2012, GUID BIOAN METH VAL
  • [5] [Anonymous], 2010, DIABETES OBES METAB, V12, P179
  • [6] Arbit Ehud, 2004, Diabetes Technol Ther, V6, P510, DOI 10.1089/1520915041705929
  • [7] Advances in the quantitation of therapeutic insulin analogues by LC-MS/MS
    Blackburn, Michael
    [J]. BIOANALYSIS, 2013, 5 (23) : 2933 - 2946
  • [8] Bowsher RR, 2011, BIOANALYSIS, V3, P883, DOI [10.4155/bio.11.50, 10.4155/BIO.11.50]
  • [9] Bowsher RR, 1999, CLIN CHEM, V45, P104
  • [10] CARTER P, 1978, CLIN CHEM, V24, P362
123